SetPoint Medical announced today that it has raised $ 30 million in a Series D funding round with funds to support the continued development of its bioelectronic therapy for the treatment of chronic inflammatory diseases. Funding for the cycle has come from existing investors including NEA, Morgenthaler, Medtronic (NYSE: MDT), Boston Scientific (NYSE: BSX), Topspin, […]